GB Patent

GB0105772D0 — Use

Assigned to Sterix Ltd · Expires 2001-04-25 · 25y expired

What this patent protects

The present invention provides use of a compound in the manufacture of a medicament to inhibit 11beta-HSD activity, wherein the compound is selected from glycyrrhetinic acid derivatives, progesterone and progesterone derivatives.

USPTO Abstract

The present invention provides use of a compound in the manufacture of a medicament to inhibit 11beta-HSD activity, wherein the compound is selected from glycyrrhetinic acid derivatives, progesterone and progesterone derivatives.

Drugs covered by this patent

Patent Metadata

Patent number
GB0105772D0
Jurisdiction
GB
Classification
—
Expires
2001-04-25
Drug substance claim
No
Drug product claim
No
Assignee
Sterix Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.